Actively Recruiting
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
Led by University of South Carolina · Updated on 2026-02-19
50
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
Sponsors
U
University of South Carolina
Lead Sponsor
P
Prisma Health-Upstate
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating how adults using GLP-1 medications for obesity or type 2 diabetes change their eating habits and what dietary support they might need. This study focuses on understanding patients' experiences and nutritional needs while on GLP-1 therapy, as current guidance mainly addresses symptom management and calorie reduction without emphasizing diet quality. The goal is to gather insights that could help improve long-term weight control and health outcomes. Participants in this observational study are adults prescribed GLP-1 therapy for obesity or type 2 diabetes who have not yet started the medication. The study observes changes over 12 weeks, measuring diet quality using the Healthy Eating Index and body weight. Participants provide information through online surveys and food recalls using smartphones and the internet. During the study, participants complete short surveys and dietary recalls at the start and after 12 weeks to track changes in diet and weight. Researchers analyze these data to understand how GLP-1 therapy affects eating patterns and nutrition. The study requires participants to consent and have regular internet access. There is no provision of free medication, and the study helps identify the support patients may need to maintain a healthy diet while using GLP-1 therapy.
CONDITIONS
Brief Title
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 and older
- Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication
- Has regular access to a smartphone and internet to complete short surveys and food recalls online
- Willing to sign informed consent.
You will not qualify if you...
- Already began the GLP-1 medication
- Have medical concerns making participation unsafe
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants who have been prescribed GLP-1 therapy are observed to assess changes in diet quality and body weight over time.
Surveys and food recalls completed online at baseline and 12 weeks
Trial Site Locations
Total: 2 locations
1
University South Carolina
Columbia, South Carolina, United States, 20208
Enrolling by Invitation
2
Prisma Health Weight Management Institute
Greenville, South Carolina, United States, 29607
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here